Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse | Annals of Internal Medicine
March 13, 2019
Recent Posts
Catching Up with Pilot Grant Recipient: Rachel Epstein
January 20, 2023
Addressing Statistical Issues Encountered in Conducting Prospective Economic Evaluations Alongside Clinical Trials
November 16, 2022
Engaging with People with Lived Experiences in OUD Modeling Research
October 16, 2022
Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons with Commercial Insurance and Likely Injection Drug Use
October 03, 2022
Where to Find CHERISH This Fall
September 27, 2022